Sprott Inc’s Medicines Co MDCO Stock Holding History

Sprott Inc’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-105,000	Closed	-$3M	–	164
2015 Q2	$3M	Sell	105,000 -15,000	-13%	-$418K	0.23%	72
2015 Q1	$3.36M	Buy	+120,000	New	+$3.37M	0.27%	71

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sprott Inc's MDCO Position: Q3 2015 in Review

Sprott Inc sold out of Medicines Co (MDCO) in Q3 2015, closing a stake of 105,000 shares — an estimated $3M sold.

Sprott Inc first reported a position in MDCO in Q1 2015 and held it in 2 quarters. The position peaked at $3.36M in Q1 2015. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

Sprott Inc reported no remaining Medicines Co position as of Q3 2015 after selling out during the quarter.
Sprott Inc sold 105,000 Medicines Co shares in Q3 2015, an estimated $3M.
Sprott Inc first reported a position in Medicines Co in Q1 2015 and held it in 2 quarters.
Sprott Inc's Medicines Co position peaked at $3.36M in Q1 2015.
183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on Sprott Inc's 13F filing for Q3 2015, filed 28 Oct 2015.